These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 28250)

  • 1. Steric aspects of dopaminergic drugs.
    Miller DD
    Fed Proc; 1978 Aug; 37(10):2392-5. PubMed ID: 28250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of dopamine receptor subtypes by comparative structure-activity relationships: dopaminomimetic activities and solid state conformation of monohydroxy-1,2,3,4,4a,5,10,10a-octahydrobenz[g]quinolines and its implications for a rotamer-based dopamine receptor model.
    Seiler MP; Markstein R; Walkinshaw MD; Boelsterli JJ
    Mol Pharmacol; 1989 May; 35(5):643-51. PubMed ID: 2566903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine D1 receptors of the calf parathyroid gland: identification and characterization.
    Niznik HB; Fogel EL; Chen CJ; Congo D; Brown EM; Seeman P
    Mol Pharmacol; 1988 Jul; 34(1):29-36. PubMed ID: 2839763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further characterization of structural requirements for agonists at the striatal dopamine D2 receptor and a comparison with those at the striatal dopamine D1 receptor. Studies with a series of monohydroxyaminotetralins on acetylcholine release from rat striatum.
    Seiler MP; Markstein R
    Mol Pharmacol; 1984 Nov; 26(3):452-7. PubMed ID: 6238231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum. Evidence that [3H]dopamine can label a high affinity agonist-binding state of the D1 dopamine receptor.
    Leff SE; Creese I
    Mol Pharmacol; 1985 Feb; 27(2):184-92. PubMed ID: 3969067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholecystokinin2 receptor-deficient mice display altered function of brain dopaminergic system.
    Kõks S; Volke V; Veraksits A; Rünkorg K; Sillat T; Abramov U; Bourin M; Huotari M; Männistö PT; Matsui T; Vasar E
    Psychopharmacology (Berl); 2001 Nov; 158(2):198-204. PubMed ID: 11702094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central mechanisms regulating penile erection in conscious rats: the dopaminergic systems related to the proerectile effect of apomorphine.
    Hsieh GC; Hollingsworth PR; Martino B; Chang R; Terranova MA; O'Neill AB; Lynch JJ; Moreland RB; Donnelly-Roberts DL; Kolasa T; Mikusa JP; McVey JM; Marsh KC; Sullivan JP; Brioni JD
    J Pharmacol Exp Ther; 2004 Jan; 308(1):330-8. PubMed ID: 14569075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine D1 and D2 receptors are sensitive to the cationic form of apomorphine.
    Seeman P; Guan HC
    Mol Pharmacol; 1987 Dec; 32(6):760-3. PubMed ID: 2961976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Light modulates dopamine-regulated Walsh inhibitor activity and dopamine-dependent cyclic AMP accumulation in the rabbit retina.
    Nowak JZ; Zawilska J; Sek B; Schorderet M
    Pol J Pharmacol Pharm; 1990; 42(5):457-70. PubMed ID: 1983030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopaminergic (4aR,10bS)-cis- and (4aS,10bS)-trans-octahydrobenzo[F]quinolines have similar pharmacophores.
    Froimowitz M; Deng Y; Jacob JN; Li N; Cody V
    Drug Des Discov; 1995 Aug; 13(1):73-81. PubMed ID: 8882902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological profile of dopamine receptor agonists as studied by brain dialysis in behaving rats.
    Imperato A; Tanda G; Frau R; Di Chiara G
    J Pharmacol Exp Ther; 1988 Apr; 245(1):257-64. PubMed ID: 3258912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced splenic natural killer cell activity in rats with a hyperreactive dopaminergic system.
    Teunis MA; Heijnen CJ; Cools AR; Kavelaars A
    Psychoneuroendocrinology; 2004 Sep; 29(8):1058-64. PubMed ID: 15219657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopaminergic activity and stereochemical considerations for rigid angular tricyclic congeners of dopamine: benzoquinoxalines and naphthothiazines.
    Perrone R; Berardi F; Tortorella V; Racagni G; Rovescalli A
    Farmaco; 1990 May; 45(5):479-88. PubMed ID: 2145846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of alpha- and beta-rotameric forms of 2-substituted octahydrobenzo[f]quinoline dopamine congeners with high and low affinity states of the anterior pituitary dopamine receptor and prolactin inhibition.
    Findell PR; Torkelson SM; Craig JC; Weiner RI
    Mol Pharmacol; 1988 Jan; 33(1):78-83. PubMed ID: 3336350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists.
    Geter-Douglass B; Katz JL; Alling K; Acri JB; Witkin JM
    J Pharmacol Exp Ther; 1997 Oct; 283(1):7-15. PubMed ID: 9336302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic interactions between the muscarinic cholinergic and dopaminergic systems in the modulation of prepulse inhibition in rats.
    Jones CK; Eberle EL; Shaw DB; McKinzie DL; Shannon HE
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1055-63. PubMed ID: 15574685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SCH23390 effects on apomorphine-induced responses of nigral dopaminergic neurons.
    Napier TC; Givens BS; Schulz DW; Bunney BS; Breese GR; Mailman RB
    J Pharmacol Exp Ther; 1986 Mar; 236(3):838-45. PubMed ID: 3512819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic activation excites rat lateral habenular neurons in vivo.
    Kowski AB; Veh RW; Weiss T
    Neuroscience; 2009 Jul; 161(4):1154-65. PubMed ID: 19374940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further definition of the D1 dopamine receptor pharmacophore: synthesis of trans-6,6a,7,8,9,13b-hexahydro-5H-benzo[d]naphth[2,1-b]azepines as rigid analogues of beta-phenyldopamine.
    Negash K; Nichols DE; Watts VJ; Mailman RB
    J Med Chem; 1997 Jul; 40(14):2140-7. PubMed ID: 9216832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between D2 dopaminergic and glutamatergic excitatory influences on lower urinary tract function in normal and cerebral-infarcted rats.
    Yokoyama O; Yoshiyama M; Namiki M; de Groat WC
    Exp Neurol; 2001 May; 169(1):148-55. PubMed ID: 11312567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.